Every day, around 500 children are born worldwide with the HIV virus.
Without treatment, half of them will die before turning two years old.
EpimolHIV Laboratory is researching how to diagnose earlier to fight against pediatric AIDS.
There are many advancements we could apply if we obtain funds. Help us ensure that more infected children reach adulthood.
Discover here everything we can achieve by continuing our research.
According to the WHO, it is estimated that by the end of 2019, there were 1.8 million children under the age of 15 living with HIV, and 150,000 new infections occurred in children worldwide.
Around 100,000 children died from AIDS.
One of the main strategies to reduce mortality and morbidity associated with pediatric HIV in these highly vulnerable populations is early diagnosis and access to antiretroviral treatment.
EpiMolVIH is an HIV research laboratory focused on the study of pediatric HIV. Our team of expert scientists is committed to developing innovative strategies to improve early HIV diagnosis and treatment to combat pediatric HIV.
EpiMolVIH is focused on advancing our comprehension of the virology, epidemiology, and pathogenesis of pediatric HIV, HIV in pregnant women, and in adults, aiming to develop innovative tools for early diagnosis and more effective treatment options.
In our HIV research laboratory, we employ state-of-the-art molecular techniques and bioinformatics tools to analyze the HIV virus and understand the host's response to the infection.
Throughout our journey , among other endeavors, we have globally analyzed variants of the HIV virus, examined the vaccination status in vulnerable populations, optimized HIV diagnosis in dried blood samples (DBS), and conducted studies on resistance to antiretrovirals in diverse populations.
Our dedication to HIV research includes pioneering new detection methods based on nanotechnology for early HIV diagnosisstarting from the first day of infection.
EpiMolVIH is focused on translating our research into clinical practice to improve the lives of children living with HIV.
To achieve this, we collaborate with both public and private institutions devoted to HIV research, along with Health Ministries and authorities leading national AIDS response plans in various countries. We establish partnerships with various hospitals in Spain, Africa, and South America.
There are many advances that we could implement with the support of funds.
Our goal is to make HIV diagnosis and treatment universally accessible, reaching countries with fewer resources or developing healthcare systems.
Your support is crucial for advancing new research projects and developing innovative strategies for the diagnosis and treatment of pediatric HIV.
With your donation, we can make a meaningful impact on the lives of children living with HIV.
Early detection method of HIV in children under 18 months.
Dr. África Holguín
With two drops of dried blood collected on a special filter paper card, HIV can be diagnosed in children under 18 months using molecular techniques. An inexpensive and simple method, perfect for countries with limited resources where the highest number of cases of pediatric HIV is concentrated.
